Targeting mutant p53 for efficient cancer therapy
VJN Bykov, SE Eriksson, J Bianchi… - Nature Reviews Cancer, 2018 - nature.com
The tumour suppressor gene TP53 is the most frequently mutated gene in cancer. Wild-type
p53 can suppress tumour development by multiple pathways. However, mutation of TP53 …
p53 can suppress tumour development by multiple pathways. However, mutation of TP53 …
Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons
M Dabrowski, Z Bukowy-Bieryllo, E Zietkiewicz - Molecular medicine, 2018 - Springer
Premature termination codons (PTCs) in the coding regions of mRNA lead to the incorrect
termination of translation and generation of non-functional, truncated proteins. Translational …
termination of translation and generation of non-functional, truncated proteins. Translational …
Effect of small molecule eRF3 degraders on premature termination codon readthrough
A Baradaran-Heravi, AD Balgi… - Nucleic acids …, 2021 - academic.oup.com
Premature termination codon (PTC) readthrough is considered a potential treatment for
genetic diseases caused by nonsense mutations. High concentrations of aminoglycosides …
genetic diseases caused by nonsense mutations. High concentrations of aminoglycosides …
Nonsense suppression therapies in human genetic diseases
P Martins-Dias, L Romão - Cellular and Molecular Life Sciences, 2021 - Springer
About 11% of all human disease-associated gene lesions are nonsense mutations, resulting
in the introduction of an in-frame premature translation-termination codon (PTC) into the …
in the introduction of an in-frame premature translation-termination codon (PTC) into the …
A quick guide to small-molecule inhibitors of eukaryotic protein synthesis
SE Dmitriev, DO Vladimirov, KA Lashkevich - Biochemistry (Moscow), 2020 - Springer
Eukaryotic ribosome and cap-dependent translation are attractive targets in the antitumor,
antiviral, anti-inflammatory, and antiparasitic therapies. Currently, a broad array of small …
antiviral, anti-inflammatory, and antiparasitic therapies. Currently, a broad array of small …
[HTML][HTML] Amlexanox enhances premature termination codon read-through in COL7A1 and expression of full length type VII collagen: potential therapy for recessive …
VS Atanasova, Q Jiang, M Prisco, C Gruber… - Journal of Investigative …, 2017 - Elsevier
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare monogenic blistering disorder
caused by the lack of functional type VII collagen, leading to skin fragility and subsequent …
caused by the lack of functional type VII collagen, leading to skin fragility and subsequent …
Deciphering the molecular mechanism of stop codon readthrough
M Palma, F Lejeune - Biological Reviews, 2021 - Wiley Online Library
Recognition of the stop codon by the translation machinery is essential to terminating
translation at the right position and to synthesizing a protein of the correct size. Under certain …
translation at the right position and to synthesizing a protein of the correct size. Under certain …
Pharmacological approaches for targeting cystic fibrosis nonsense mutations
J Sharma, KM Keeling, SM Rowe - European journal of medicinal chemistry, 2020 - Elsevier
Cystic fibrosis (CF) is a monogenic autosomal recessive disorder. The clinical
manifestations of the disease are caused by∼ 2,000 mutations in the cystic fibrosis …
manifestations of the disease are caused by∼ 2,000 mutations in the cystic fibrosis …
Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process
A Wittenstein, M Caspi, I Rippin, O Elroy-Stein… - PLoS …, 2023 - journals.plos.org
The introduction of premature termination codons (PTCs), as a result of splicing defects,
insertions, deletions, or point mutations (also termed nonsense mutations), lead to …
insertions, deletions, or point mutations (also termed nonsense mutations), lead to …
Pharmaceuticals promoting premature termination codon readthrough: progress in development
S Li, J Li, W Shi, Z Nie, S Zhang, F Ma, J Hu, J Chen… - Biomolecules, 2023 - mdpi.com
Around 11% of all known gene lesions causing human genetic diseases are nonsense
mutations that introduce a premature stop codon (PTC) into the protein-coding gene …
mutations that introduce a premature stop codon (PTC) into the protein-coding gene …